Journal of Microbiology and Biotechnology

The Korean Society for Microbiology and Biotechnology (한국미생물·생명공학회)
권호 표지
DOI QR코드

DOI QR Code

Helicobacter pylori-Induced Progranulin Promotes the Progression of the Gastric Epithelial Cell Cycle by Regulating CDK4

  • Ren, Zongjiao (Department of Pathogenic Microbiology, Basic Medical College, Weifang Medical University) ;
  • Li, Jiayi (Department of Pathogenic Microbiology, Basic Medical College, Weifang Medical University) ;
  • Du, Xianhong (Department of Pathogenic Microbiology, Basic Medical College, Weifang Medical University) ;
  • Shi, Wenjing (Department of Gynecology, Weifang Medical University Affiliated Hospital) ;
  • Guan, Fulai (Laboratory of Morphology, Weifang Medical University) ;
  • Wang, Xiaochen (Department of Pathogenic Microbiology, Basic Medical College, Weifang Medical University) ;
  • Wang, Linjing (Clinical Medical College, Weifang Medical University) ;
  • Wang, Hongyan (Department of Pathogenic Microbiology, Basic Medical College, Weifang Medical University)
  • Received : 2022.03.28
  • Accepted : 2022.06.16
  • Published : 2022.07.28
Download PDF
⟨ Previous Next ⟩

Abstract

Helicobacter pylori, a group 1 carcinogen, colonizes the stomach and affects the development of stomach diseases. Progranulin (PGRN) is an autocrine growth factor that regulates multiple cellular processes and plays a tumorigenic role in many tissues. Nevertheless, the mechanism of action of PGRN in gastric cancer caused by H. pylori infection remains unclear. Here, we investigated the role of PGRN in cell cycle progression and the cell proliferation induced by H. pylori infection. We found that the increased PGRN was positively associated with CDK4 expression in gastric cancer tissue. PGRN was upregulated by H. pylori infection, thereby promoting cell proliferation, and that enhanced level of proliferation was reduced by PGRN inhibitor. CDK4, a target gene of PGRN, is a cyclin-dependent kinase that binds to cyclin D to promote cell cycle progression, which was upregulated by H. pylori infection. We also showed that knockdown of CDK4 reduced the higher cell cycle progression caused by upregulated PGRN. Moreover, when the PI3K/Akt signaling pathway (which is promoted by PGRN) was blocked, the upregulation of CDK4 mediated by PGRN was reduced. These results reveal the potential mechanism by which PGRN plays a major role through CDK4 in the pathological mechanism of H. pylori infection.

Keywords

Acknowledgement

This study was supported by the National Natural Science Foundation of China (No. 81201262). We thank Prof. IC Bruce for critical reading of the manuscript.

References

  1. Ford AC, Yuan Y, Moayyedi P. 2020. Helicobacter pylori eradication therapy to prevent gastric cancer: systematic review and metaanalysis. Gut 69: 2113-2121. https://doi.org/10.1136/gutjnl-2020-320839
  2. Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. 2021. Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 71: 209-249. https://doi.org/10.3322/caac.21660
  3. Karimi P, Islami F, Anandasabapathy S, Freedman ND, Kamangar F. 2014. Gastric cancer: descriptive epidemiology, risk factors, screening, and prevention. Cancer Epidemiol. Biomarkers Prev. 23: 700-713. https://doi.org/10.1158/1055-9965.EPI-13-1057
  4. Song Z, Wu Y, Yang J, Yang D, Fang X. 2017. Progress in the treatment of advanced gastric cancer. Tumour Biol. 39: 1010428317714626.
  5. Schistosomes, liver flukes and Helicobacter pylori. IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. Lyon, 7-14 June 1994. IARC Monogr. Eval. Carcinog. Risks Hum. 61: 1-241.
  6. Gonzalez CA, Megraud F, Buissonniere A, Lujan Barroso L, Agudo A, Duell EJ, et al. 2012. Helicobacter pylori infection assessed by ELISA and by immunoblot and noncardia gastric cancer risk in a prospective study: the Eurgast-EPIC project. Ann. Oncol. 23: 1320-1324. https://doi.org/10.1093/annonc/mdr384
  7. Hooi JKY, Lai WY, Ng WK, Suen MMY, Underwood FE, Tanyingoh D, et al. 2017. Global prevalence of Helicobacter pylori infection: Systematic review and meta-analysis. Gastroenterology 153: 420-429. https://doi.org/10.1053/j.gastro.2017.04.022
  8. Cho J, Prashar A, Jones NL, Moss SF. 2021. Helicobacter pylori infection. Gastroenterol. Clin. North Am. 50: 261-282. https://doi.org/10.1016/j.gtc.2021.02.001
  9. Wang F, Meng W, Wang B, Qiao L. 2014. Helicobacter pylori-induced gastric inflammation and gastric cancer. Cancer Lett. 345: 196-202. https://doi.org/10.1016/j.canlet.2013.08.016
  10. Hochegger H, Takeda S, Hunt T. 2008. Cyclin-dependent kinases and cell-cycle transitions: does one fit all? Nat. Rev. Mol. Cell Biol. 9: 910-916. https://doi.org/10.1038/nrm2510
  11. Enders GH. 2012. Mammalian interphase cdks: dispensable master regulators of the cell cycle. Genes Cancer 3: 614-618. https://doi.org/10.1177/1947601913479799
  12. Gao X, Leone GW, Wang H. 2020. Cyclin D-CDK4/6 functions in cancer. Adv. Cancer Res. 148: 147-169. https://doi.org/10.1016/bs.acr.2020.02.002
  13. Tadesse S, Caldon EC, Tilley W, Wang S. 2019. Cyclin-eependent kinase 2 inhibitors in cancer therapy: An update. J. Med. Chem. 62: 4233-4251. https://doi.org/10.1021/acs.jmedchem.8b01469
  14. Kastan MB, Bartek J. 2004. Cell-cycle checkpoints and cancer. Nature 432: 316-323. https://doi.org/10.1038/nature03097
  15. Ford HL, Pardee AB. 1999. Cancer and the cell cycle. J. Cell Biochem. Suppl 32-33: 166-172. https://doi.org/10.1002/(SICI)1097-4644(1999)75:32+<166::AID-JCB20>3.0.CO;2-J
  16. Sherr CJ. 1996. Cancer cell cycles. Science 274: 1672-1677. https://doi.org/10.1126/science.274.5293.1672
  17. Fong LY, Nguyen VT, Farber JL, Huebner K, Magee PN. 2000. Early deregulation of the the p16ink4a-cyclin D1/cyclin-dependent kinase 4-retinoblastoma pathway in cell proliferation-driven esophageal tumorigenesis in zinc-deficient rats. Cancer Res. 60: 4589-4595.
  18. Guha R, Yue B, Dong J, Banerjee A, Serrero G. 2021. Anti-progranulin/GP88 antibody AG01 inhibits triple negative breast cancer cell proliferation and migration. Breast Cancer Res. Treat. 186: 637-653. https://doi.org/10.1007/s10549-021-06120-y
  19. Zhao J, Li X, Liu J, Jiang W, Wen D, Xue H. 2018. Effect of progranulin on migration and invasion of human colon cancer cells. J. Coll. Physicians Surg. Pak. 28: 607-611. https://doi.org/10.29271/jcpsp.2018.08.607
  20. Walsh CE, Hitchcock PF. 2017. Progranulin regulates neurogenesis in the developing vertebrate retina. Dev. Neurobiol. 77: 1114-1129. https://doi.org/10.1002/dneu.22499
  21. He Z, Ong CH, Halper J, Bateman A. 2003. Progranulin is a mediator of the wound response. Nat. Med. 9: 225-229. https://doi.org/10.1038/nm816
  22. Wei J, Zhang L, Ding Y, Liu R, Guo Y, Hettinghouse A, et al. 2020. Progranulin promotes diabetic fracture healing in mice with type 1 diabetes. Ann. NY Acad. Sci. 1460: 43-56. https://doi.org/10.1111/nyas.14208
  23. Xu B, Chen X, Ding Y, Chen C, Liu T, Zhang H. 2020. Abnormal angiogenesis of placenta in progranulindeficient mice. Mol. Med. Rep. 22: 3482-3492.
  24. Lu J, Huang J, Shan M, Hu X, Guo W, Xie W, et al. 2021. Progranulin ameliorates lung inflammation in an LPS-induced acute lung injury mouse model by modulating macrophage polarization and the MAPK pathway. Ann. Clin. Lab. Sci. 51: 220-230.
  25. Li H, Zhang Z, Feng D, Xu L, Li F, Liu J, et al. 2020. PGRN exerts inflammatory effects via SIRT1-NF-kappaB in adipose insulin resistance. J. Mol. Endocrinol. 64: 181-193. https://doi.org/10.1530/JME-19-0211
  26. Feng JQ, Guo FJ, Jiang BC, Zhang Y, Frenkel S, Wang DW, et al. 2010. Granulin epithelin precursor: a bone morphogenic protein 2- inducible growth factor that activates Erk1/2 signaling and JunB transcription factor in chondrogenesis. FASEB J. 24: 1879-1892. https://doi.org/10.1096/fj.09-144659
  27. Abdulrahman A, Eckstein M, Jung R, Guzman J, Weigelt K, Serrero G, et al. 2019. Expression of GP88 (Progranulin) protein is an independent prognostic factor in prostate cancer patients. Cancers (Basel). 11: 2029.
  28. Feng T, Zheng L, Liu F, Xu X, Mao S, Wang X, et al. 2016. Growth factor progranulin promotes tumorigenesis of cervical cancer via PI3K/Akt/mTOR signaling pathway. Oncotarget 7: 58381-58395. https://doi.org/10.18632/oncotarget.11126
  29. Kimura A, Takemura M, Serrero G, Yoshikura N, Hayashi Y, Saito K, et al. 2018. Higher levels of progranulin in cerebrospinal fluid of patients with lymphoma and carcinoma with CNS metastasis. J. Neurooncol. 137: 455-462. https://doi.org/10.1007/s11060-017-2742-z
  30. Yang D, Wang LL, Dong TT, Shen YH, Guo XS, Liu CY, et al. 2015. Progranulin promotes colorectal cancer proliferation and angiogenesis through TNFR2/Akt and ERK signaling pathways. Am. J. Cancer Res. 5: 3085-3097.
  31. Buraschi S, Neill T, Xu SQ, Palladino C, Belfiore A, Iozzo RV, et al. 2020. Progranulin/EphA2 axis: A novel oncogenic mechanism in bladder cancer. Matrix Biol. 93: 10-24. https://doi.org/10.1016/j.matbio.2020.03.009
  32. Yabe K, Yamamoto Y, Takemura M, Hara T, Tsurumi H, Serrero G, et al. 2021. Progranulin depletion inhibits proliferation via the transforming growth factor beta/SMAD family member 2 signaling axis in Kasumi-1 cells. Heliyon 7: e05849.
  33. Fang W, Zhou T, Shi H, Yao M, Zhang D, Qian H, et al. 2021. Progranulin induces immune escape in breast cancer via up-regulating PD-L1 expression on tumor-associated macrophages (TAMs) and promoting CD8(+ ) T cell exclusion. J. Exp. Clin. Cancer Res. 40: 4.
  34. Zhou C, Huang Y, Wu J, Wei Y, Chen X, Lin Z, et al. 2021. A narrative review of multiple mechanisms of progranulin in cancer: a potential target for anti-cancer therapy. Transl. Cancer Res. 10: 4207-4216. https://doi.org/10.21037/tcr-20-2972
  35. Liu B, Li X, Sun F, Tong X, Bai Y, Jin K, et al. 2019. HP-CagA+ regulates the expression of CDK4/CyclinD1 via reg3 to change cell cycle and promote cell proliferation. Int. J. Mol. Sci. 21: 224.
  36. Wang H, Sun Y, Liu S, Yu H, Li W, Zeng J, et al. 2011. Upregulation of progranulin by Helicobacter pylori in human gastric epithelial cells via p38MAPK and MEK1/2 signaling pathway: role in epithelial cell proliferation and migration. FEMS Immunol. Med. Microbiol. 63: 82-92. https://doi.org/10.1111/j.1574-695X.2011.00833.x
  37. Livak KJ, Schmittgen TD. 2001. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 25: 402-408. https://doi.org/10.1006/meth.2001.1262
  38. Tang W, Lu Y, Tian QY, Zhang Y, Guo FJ, Liu GY, et al. 2011. The growth factor progranulin binds to TNF receptors and is therapeutic against inflammatory arthritis in mice. Science 332: 478-484. https://doi.org/10.1126/science.1199214
  39. Arechavaleta-Velasco F, Perez-Juarez CE, Gerton GL, Diaz-Cueto L. 2017. Progranulin and its biological effects in cancer. Med. Oncol. 34: 194.
  40. Jian J, Li G, Hettinghouse A, Liu C. 2018. Progranulin: A key player in autoimmune diseases. Cytokine 101: 48-55. https://doi.org/10.1016/j.cyto.2016.08.007
  41. Demorrow S. 2013. Progranulin: a novel regulator of gastrointestinal cancer progression. Transl. Gastrointest. Cancer 2: 145-151.
  42. Dong T, Yang D, Li R, Zhang L, Zhao H, Shen Y, et al. 2016. PGRN promotes migration and invasion of epithelial ovarian cancer cells through an epithelial mesenchymal transition program and the activation of cancer associated fibroblasts. Exp. Mol. Pathol. 100: 17-25. https://doi.org/10.1016/j.yexmp.2015.11.021
  43. Klupp F, Kahlert C, Franz C, Halama N, Schleussner N, Wirsik NM, et al. 2021. Granulin: an invasive and survival-determining marker in colorectal cancer patients. Int. J. Mol. Sci. 22: 6436.
  44. Wang W, Hayashi J, Kim WE, Serrero G. 2003. PC cell-derived growth factor (granulin precursor) expression and action in human multiple myeloma. Clin. Cancer Res. 9: 2221-2228.
  45. Lu R, Serrero G. 2000. Inhibition of PC cell-derived growth factor (PCDGF, epithelin/granulin precursor) expression by antisense PCDGF cDNA transfection inhibits tumorigenicity of the human breast carcinoma cell line MDA-MB-468. Proc. Natl. Acad. Sci. USA 97: 3993-3998. https://doi.org/10.1073/pnas.97.8.3993
  46. Serrero G, Hawkins DM, Yue B, Ioffe O, Bejarano P, Phillips JT, et al. 2012. Progranulin (GP88) tumor tissue expression is associated with increased risk of recurrence in breast cancer patients diagnosed with estrogen receptor positive invasive ductal carcinoma. Breast Cancer Res. 14: R26.
  47. Ho JC, Ip YC, Cheung ST, Lee YT, Chan KF, Wong SY, et al. 2008. Granulin-epithelin precursor as a therapeutic target for hepatocellular carcinoma. Hepatology 47: 1524-1532. https://doi.org/10.1002/hep.22191
  48. Wu JY, Lee YC, Graham DY. 2019. The eradication of Helicobacter pylori to prevent gastric cancer: a critical appraisal. Expert Rev. Gastroenterol. Hepatol. 13: 17-24. https://doi.org/10.1080/17474124.2019.1542299
  49. Zhou Z, Ye G, Peng J, He B, Xu S, Fan W, et al. 2021. Expression of Wnt3, beta-catenin and MMP-7 in gastric cancer and precancerous lesions and their correlations with Helicobacter pylori infection. Zhong Nan Da Xue Xue Bao Yi Xue Ban 46: 575-582.
  50. Molaei F, Forghanifard MM, Fahim Y, Abbaszadegan MR. 2018. Molecular signaling in tumorigenesis of gastric cancer. Iran Biomed. J. 22: 217-230. https://doi.org/10.29252/ibj.22.4.217
  51. Padda J, Khalid K, Cooper AC, Jean-Charles G. 2021. Association between Helicobacter pylori and gastric carcinoma. Cureus 13: e15165.
  52. Kato MV, Sato H, Anzai H, Nagayoshi M, Ikawa Y. 1997. Up-regulation of cell cycle-associated genes by p53 in apoptosis of an erythroleukemic cell line. Leukemia 11 Suppl 3: 389-392.
  53. Woodward TA, Klingler PD, Genko PV, Wolfe JT. 2000. Barrett's esophagus, apoptosis and cell cycle regulation: correlation of p53 with Bax, Bcl-2 and p21 protein expression. Anticancer Res. 20: 2427-2432.
  54. Chinzei N, Hayashi S, Ueha T, Fujishiro T, Kanzaki N, Hashimoto S, et al. 2015. P21 deficiency delays regeneration of skeletal muscular tissue. PLoS One 10: e0125765.
  55. Megraud F, Bessede E, Varon C. 2015. Helicobacter pylori infection and gastric carcinoma. Clin. Microbiol. Infect. 21: 984-990. https://doi.org/10.1016/j.cmi.2015.06.004
  56. Evan GI, Vousden KH. 2001. Proliferation, cell cycle and apoptosis in cancer. Nature 411: 342-348. https://doi.org/10.1038/35077213
  57. Kar S. 2016. Unraveling cell-cycle dynamics in cancer. Cell Syst. 2: 8-10. https://doi.org/10.1016/j.cels.2016.01.007
  58. Pack LR, Daigh LH, Meyer T. 2019. Putting the brakes on the cell cycle: mechanisms of cellular growth arrest. Curr. Opin. Cell Biol. 60: 106-113. https://doi.org/10.1016/j.ceb.2019.05.005
  59. Campbell GJ, Hands EL, Van de Pette M. 2020. The role of CDKs and CDKIs in murine development. Int. J. Mol. Sci. 21: 5343.
  60. Canepa ET, Scassa ME, Ceruti JM, Marazita MC, Carcagno AL, Sirkin PF, et al. 2007. INK4 proteins, a family of mammalian CDK inhibitors with novel biological functions. IUBMB Life 59: 419-426. https://doi.org/10.1080/15216540701488358
  61. Jackson RJ, Adnane J, Coppola D, Cantor A, Sebti SM, Pledger WJ. 2002. Loss of the cell cycle inhibitors p21(Cip1) and p27(Kip1) enhances tumorigenesis in knockout mouse models. Oncogene 21: 8486-8497. https://doi.org/10.1038/sj.onc.1205946
  62. Ahmed A, Smoot D, Littleton G, Tackey R, Walters CS, Kashanchi F, et al. 2000. Helicobacter pylori inhibits gastric cell cycle progression. Microbes Infect. 2: 1159-1169. https://doi.org/10.1016/S1286-4579(00)01270-3
  63. Li N, Xie C, Lu NH. 2016. p53, a potential predictor of Helicobacter pylori infection-associated gastric carcinogenesis? Oncotarget 7: 66276-66286. https://doi.org/10.18632/oncotarget.11414
  64. Sherr CJ. 1995. D-type cyclins. Trends Biochem. Sci. 20: 187-190. https://doi.org/10.1016/S0968-0004(00)89005-2
  65. Shirin H, Sordillo EM, Oh SH, Yamamoto H, Delohery T, Weinstein IB, et al. 1999. Helicobacter pylori inhibits the G1 to S transition in AGS gastric epithelial cells. Cancer Res. 59: 2277-2281.
  66. Scotti C, Sommi P, Pasquetto MV, Cappelletti D, Stivala S, Mignosi P, et al. 2010. Cell-cycle inhibition by Helicobacter pylori Lasparaginase. PLoS One 5: e13892.
  67. Cover TL, Krishna US, Israel DA, Peek RM, Jr. 2003. Induction of gastric epithelial cell apoptosis by Helicobacter pylori vacuolating cytotoxin. Cancer Res. 63: 951-957.
  68. Kim KM, Lee SG, Kim JM, Kim DS, Song JY, Kang HL, et al. 2010. Helicobacter pylori gamma-glutamyltranspeptidase induces cell cycle arrest at the G1-S phase transition. J. Microbiol. 48: 372-377. https://doi.org/10.1007/s12275-010-9293-8
  69. Li H, Liang D, Hu N, Dai X, He J, Zhuang H, et al. 2019. Helicobacter pylori inhibited cell proliferation in human periodontal ligament fibroblasts through the Cdc25C/CDK1/cyclinB1 signaling cascade. J. Periodontal. Implant Sci. 49: 138-147. https://doi.org/10.5051/jpis.2019.49.3.138
  70. Alquezar C, Esteras N, Bartolome F, Merino JJ, Alzualde A, Lopez de Munain A, et al. 2012. Alteration in cell cycle-related proteins in lymphoblasts from carriers of the c.709-1G>A PGRN mutation associated with FTLD-TDP dementia. Neurobiol. Aging 33: 429.e427-420.
  71. Alquezar C, Esteras N, de la Encarnacion A, Alzualde A, Moreno F, Lopez de Munain A, et al. 2014. PGRN haploinsufficiency increased Wnt5a signaling in peripheral cells from frontotemporal lobar degeneration-progranulin mutation carriers. Neurobiol. Aging 35: 886-898. https://doi.org/10.1016/j.neurobiolaging.2013.09.021
  72. Teo ZL, Versaci S, Dushyanthen S, Caramia F, Savas P, Mintoff CP, et al. 2017. Combined CDK4/6 and PI3Kalpha inhibition is synergistic and immunogenic in triple-negative breast cancer. Cancer Res. 77: 6340-6352. https://doi.org/10.1158/0008-5472.CAN-17-2210
  73. Kollmann K, Briand C, Bellutti F, Schicher N, Blunder S, Zojer M, et al. 2019. The interplay of CDK4 and CDK6 in melanoma. Oncotarget 10: 1346-1359. https://doi.org/10.18632/oncotarget.26515
  74. Lu Y, Zheng L, Zhang W, Feng T, Liu J, Wang X, et al. 2014. Growth factor progranulin contributes to cervical cancer cell proliferation and transformation in vivo and in vitro. Gynecol. Oncol. 134: 364-371. https://doi.org/10.1016/j.ygyno.2014.05.025
  75. He Z, Ismail A, Kriazhev L, Sadvakassova G, Bateman A. 2002. Progranulin (PC-cell-derived growth factor/acrogranin) regulates invasion and cell survival. Cancer Res. 62: 5590-5596.
  76. Peek RM, Jr., Wirth HP, Moss SF, Yang M, Abdalla AM, Tham KT, et al. 2000. Helicobacter pylori alters gastric epithelial cell cycle events and gastrin secretion in Mongolian gerbils. Gastroenterology 118: 48-59. https://doi.org/10.1016/S0016-5085(00)70413-6